Accuray Incorporated (ARAY) is a Healthcare · Medical Devices company listed on NASDAQ. Price $0.23 (-2.49%), Market cap $0.03B, 52-week low–high $0.27 ~ $1.85.
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiatio
Financial statements, price targets, institutional (13F) holdings and related news for Accuray Incorporated are updated in real time on BlackAll Trade.
Accuray Incorporated trades at $0.23 (-2.49%). Real-time quotes and charts are available on BlackAll Trade.
Accuray Incorporated has a market cap of about $0.03B.
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, As